Plasma from recovered COVID patients works better if it has more antibodies

Embargoed until: Publicly released: 2021-01-14 09:00

International

COVID patients who receive blood plasma with higher SARS-CoV-2 antibody levels had a lower risk of death than those who received plasma with lower antibody levels, according to US research. This sort of treatment, known as convalescent plasma, has been widely used to treat COVID-19, and it involved using blood plasma from recovered COVID-19 patients to treat current patients, in the hope that the plasma contains potentially therapeutic antibodies that can be passed on the patient.

Media release

From:

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Massachusetts Medical Society, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).

Journal/
conference: New England Journal of Medicine

Research:Paper

Organisation/s: Mayo Clinic, USA

Funder: Funded by the Department of Health and Human Services and others; ClinicalTrials.gov number, NCT04338360

Media Contact/s

Contact details are only visible to registered journalists.